FindTrial
Sign In

BNP

DIAGNOSTIC_TEST8 trials

Sponsors

Mayo Clinic, Medical University of Vienna, Assistance Publique - Hôpitaux de Paris, Yale University, Vanderbilt University Medical Center

Conditions

Chronic Coronary SyndromeChronic Coronary Total OcclusionCoronary Arterial Disease (CAD)HealthyHeart FailureHypertensionMelanomaMeningococcal Infections

Phase 1

Low Dose Intravenous (IV) Infusion of BNP in the Presence and Absence of Acute Type V Phosphodiesterase (PDE V) in Improving Renal Function in Hospitalized Chronic Heart Failure (CHF) Patients With Renal Dysfunction
CompletedNCT00972569
Mayo ClinicHeart Failure, Renal Dysfunction
Start: 2009-10-31End: 2019-12-31Updated: 2020-01-18
A Sunscreen Based on Bioadhesive Nanoparticles
CompletedNCT02668536
Yale UniversityMelanoma, UV Ray Skin Damage
Start: 2017-07-17End: 2017-08-18Updated: 2018-03-13

Phase 4

Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1
TerminatedNCT03738878
Vanderbilt University Medical CenterHypertension
Start: 2018-11-15End: 2024-12-01Updated: 2025-08-03

Unknown Phase

Brain Natriuretic Peptide Effects on Appetite Regulating Hormones and Endothelial Derived Peptides
CompletedNCT01375153
Medical University of ViennaHealthy
Start: 2010-11-30End: 2011-05-31Updated: 2017-04-06
Septic cArdiac Deficiency and MenIngococcal seveRe Sepsis
CompletedNCT02041663
Assistance Publique - Hôpitaux de ParisMeningococcal Infections, Septic Shock, Severe Sepsis
Start: 2012-03-05End: 2018-07-11Updated: 2023-08-28
Access BNP Clinical Enrollment Study
CompletedNCT06624293
Beckman Coulter, Inc.Heart Failure
Start: 2024-08-30End: 2025-02-18Updated: 2025-04-23
Association of Plasma N-terminal Pro-Brain Natriuretic Peptide Levels With the Burden of Coronary Artery Disease
RecruitingNCT07013344
IRCCS Ospedale San RaffaeleChronic Coronary Syndrome, Chronic Coronary Total Occlusion, Coronary Arterial Disease (CAD) +2
Start: 2021-09-01End: 2025-07-31Target: 800Updated: 2025-06-10
Access BNP Clinical Performance Evaluation: Testing and Clinical Concordance Study
CompletedNCT07217431
Beckman Coulter, Inc.Heart Failure
Start: 2024-10-10End: 2025-03-25Updated: 2025-10-16

Related Papers

Renal Effects of Combination Phosphodiesterase V Inhibition and Low-Dose B-Type Natriuretic Peptide in Acute Heart Failure: A Randomized Clinical Trial
Circulation Heart Failure2024-11-081 citations
Abstract 15217: Combination Phosphodiesterase V Inhibition and Low Dose B-type Natriuretic Peptide Did Not Enhance Renal Function in Acute Heart Failure
Circulation2020-11-17